Skip to main content
Premium Trial:

Request an Annual Quote

BioInformatics Briefs: Jan 14, 2002




VizX Labs, a Seattle bioinformatics startup founded in February 2001, said last week that it has acquired NeoBase, also of Seattle. The combined company will operate under the name of VizX Labs LLC and plans to develop a suite of bioinformatics tools for microarray analysis.

In the acquisition, VizX Labs purchased NeoBase assets for an undisclosed sum of cash and stock. In addition to its line of OrderMaker supply ordering and budgeting software, NeoBase assets include beta-stage microarray analytical software. VizX said it would continue to market NeoBase’s OrderMakerPro software, but intends to focus its future efforts on microarray software.

VizX said its first microarray software product — a platform-independent, Web-based system customizable for data collection and management — would be commercially introduced in Spring 2002.

VizX is also developing software to optimize probe and microarray experiment design.




Strand Genomics, a bioinformatics company based in Bangalore, India, has signed Syrrx as the first customer for its recently released Sphatika image classification software.

Sphatika automates image classification during the crystal growth process in X-ray crystallography. Strand granted Syrrx of San Diego an exclusive license to the software.


PerkinElmer said last week that it has agreed to distribute Nonlinear Dynamics’ Proteome 1-D Analyzer software for image analysis, identification, and protein picking from one-dimensional protein gels.

The agreement builds upon an earlier agreement in which PerkinElmer Life Sciences agreed to distribute Nonlinear’s Progenesis 2D electrophoresis image analysis software [BioInform, 08-06-01].

Under the new agreement, PerkinElmer Life Sciences will sell Proteome 1-D Analyzer, which was jointly developed by Nonlinear and PerkinElmer and interfaces solely with the PerkinElmer-supported protein picking robot, the ProPic, from Genomic Solutions.




Cellzome of Heidelberg, Germany, has made its Yeast Protein Complex Database freely available at

The database includes data from a study the company published in the January 10 issue of Nature describing the first draft of a functional map of the Saccharomyces cerevisae proteome.

The map visualizes an entire network of protein complexes and their interactions in yeast. It characterizes the function and interactions of 1,440 yeast proteins comprising 232 multi-protein complexes.




Herndon, Va.-based Illumitek made its life sciences debut last week as Viaken Systems chose to add the company’s D3 data and process integration platform to its suite of integration tools.

The D3 (Detection-Delivery-Direction) platform integrates data mining, analysis, visualization, and Web-based interactivity into one development platform, according to Illumitek, and “extends the capability of our platform,” said Viaken founder and CEO Keith Elliston.

Illumitek was spun out of business intelligence software firm SPSS in early 2001.




Stanford University’s Robert Tibshirani and Trevor Hastie will offer a short course on statistical learning and data mining for bioinformatics at the Sheraton Hotel in Palo Alto, Calif., Feb. 28-March 1, 2002.

The first day of the course will focus on methods for supervised learning,while the second day will cover unsupervised learning. Further information is available at:


The National Center for Genome Resources will hold a Workshop on Bioinformatics Training March 11-15, 2002, at the NCGR headquarters in Santa Fe, NM.

The workshop will cover gene identification and annotation, complexity analysis of sequences and structures, gene expression data analysis, and database creation. See School.html for further details.


The Bioinformatics Laboratory at the National University of Ireland, Maynooth, will hold its Fourth International Bioinformatics Summer School June 24-28th, 2002.

Topics for the session include databases, pairwise and multiple alignment, phylogeny reconstruction, protein structure prediction, microarray analysis, ORF prediction, and genome assembly.

Further information is available at:, or by e-mail to: [email protected].

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.